| Literature DB >> 25593905 |
Batool H Zegaer1, Anastasios Ioannidis2, George C Babis3, Vassiliki Ioannidou1, Athanassios Kossyvakis4, Sotiris Bersimis5, Joseph Papaparaskevas6, Efthimia Petinaki7, Paraskevi Pliatsika1, Stylianos Chatzipanagiotou1.
Abstract
Intraoperative conventional bacteriological cultures were compared with different polymerase chain reaction (PCR) methods in patients with total joint arthroplasties. The isolated bacteria were investigated for biofilm formation, and the biofilm forming strains, in their planktonic and biofilm forms, were further tested for their antimicrobial resistance against several clinically important antimicrobials. Forty four bone and joint samples were included and classified as infected or non-infected according to standard criteria for periprosthetic hip and knee infections. For the bacteriological diagnosis, conventional culture, two types of universal PCR and species specific PCR for three selected pathogens (Staphylococcus aureus, Staphylococcus epidermidis, and Pseudomonas aeruginosa) were applied. Biofilm formation determination was performed by the tissue culture plate method. Antimicrobial susceptibility of the planktonic bacteria was performed by the minimal inhibitory concentration determination and, of the biofilm forms, by the minimal inhibitory concentration for bacterial regrowth from the biofilm. Twenty samples were culture positive, with S. epidermidis, S. aureus, or P. aeruginosa. All PCR methods were very ineffective in detecting only one pathogen. All isolates were biofilm positive and their biofilm forms, were highly resistant. In this study, compared to PCR, culture remains the "gold standard." The biofilm formation by the causative bacteria and the concomitant manifold increased antimicrobial resistance may explain the clinical failure of treatment in some cases and should be considered in the future for therapeutic planning.Entities:
Keywords: PCR; antimicrobial resistance; biofilms; culture; periprosthetic joint infection
Year: 2014 PMID: 25593905 PMCID: PMC4291888 DOI: 10.3389/fmed.2014.00030
Source DB: PubMed Journal: Front Med (Lausanne) ISSN: 2296-858X
PCR primers and annealing temperatures for the detection of bacteria causing periprosthetic joint infections.
| Target gene for | Sequence (5′ → 3′) | Annealing temp. (°C) | Product (bp) |
|---|---|---|---|
| 16S rRNA universal 1 ( | AGAGTTTGATCCTGGCTCAG | 59 | ~1380 |
| GACGGGCGGTGTGTACAA | |||
| 16S rRNA universal 2 ( | AGTTTGATCCTGGCTCAG | 55 | ~1450 |
| AGGCCCGGGAACGTATTCAC | |||
| CTTTGTCGGTACACGATATTCTTCACG | 54 | 108 | |
| CGTAATGAGATTTCAGTAGATAATACAACA | |||
| ATCAAAAAGTTGGCGAACCTTTTCA | 50 | 124 | |
| CAAAAGAGCGTGGAGAAAAGTATCA | |||
| GGGGGATCTTCGGACCTCA | 58 | 956 | |
| TCCTTAGAGTGCCCACCCG |
The results of universal and specific PCR technique for the culture (A) positive samples and (B) negative samples.
| Patient no. | Preoperative diagnosis | Culture | Universal 1 PCR [19] | Universal 2 PCR [20] | PCR | PCR | PCR |
|---|---|---|---|---|---|---|---|
| 1 | Infected | N | N | N | N | N | |
| 2 | Infected | P/no id. | P/no id. | P | P | P | |
| 3 | Non-infected | N | N | N | N | N | |
| 4 | Infected | N | N | N | N | N | |
| 5 | Infected | P/no id. | P/no id. | P | P | N | |
| 6 | Infected | N | N | N | N | N | |
| 7 | Non-infected | N | N | N | N | N | |
| 8 | Infected | N | N | N | N | N | |
| 9 | Non-infected | N | N | N | N | N | |
| 10 | Infected | N | N | N | P | N | |
| 11 | Infected | N | N | P | N | N | |
| 12 | Infected | P/no id. | P/no id. | P | P | P | |
| 13 | Infected | N | N | N | N | P | |
| 14 | Infected | N | N | P | N | N | |
| 15 | Infected | N | N | N | N | N | |
| 16 | Non-infected | N | P/no id. | P | P | P | |
| 17 | Non-infected | N | N | N | N | N | |
| 18 | Non-infected | N | N | P | N | N | |
| 19 | Infected | N | N | P | N | P | |
| 20 | Non-infected | N | N | P | P | N | |
| 21 | Non-infected | N | N | N | N | N | N |
| 22 | Non-infected | N | N | N | N | N | N |
| 23 | Non-infected | N | N | N | N | N | N |
| 24 | Non-infected | N | N | N | N | N | N |
| 25 | Non-infected | N | N | N | N | P | N |
| 26 | Non-infected | N | N | N | P | P | N |
| 27 | Non-infected | N | N | N | N | N | N |
| 28 | Non-infected | N | N | N | N | N | N |
| 29 | Non-infected | N | N | N | N | N | N |
| 30 | Non-infected | N | N | N | N | P | N |
| 31 | Non-infected | N | N | N | P | P | P |
| 32 | Non-infected | N | N | N | N | N | N |
| 33 | Non-infected | N | N | N | N | N | N |
| 34 | Non-infected | N | N | N | N | N | N |
| 35 | Non-infected | N | N | N | N | N | N |
| 36 | Non-infected | N | N | N | P | P | N |
| 37 | Non-infected | N | N | N | N | P | P |
| 38 | Non-infected | N | N | N | N | P | N |
| 39 | Non-infected | N | N | N | N | N | N |
| 40 | Non-infected | N | N | N | N | N | N |
| 41 | Non-infected | N | N | N | N | P | N |
| 42 | Non-infected | N | N | N | N | N | N |
| 43 | Non-infected | N | N | N | N | N | N |
| 44 | Non-infected | N | N | N | N | N | N |
N = negative, P = positive, no id. = no identification.
White blood cell (WBC), C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) preoperative determination in the blood of the patients subject to total joint arthroplasty.
| Parameter | Mean value (S.D.) | |||
|---|---|---|---|---|
| Total ( | Non-infected ( | Infected ( | ||
| WBC (X 103 cells/μl) | 9.33 (2.889) | 7.72 (1.294) | 13.15 (1.790) | <0.001 |
| CRP (mg/dl) | 5.67 (7.609) | 1.56 (1.085) | 15.47 (7.528) | <0.001 |
| ESR | 34.36 (27.510) | 20.71 (12.006) | 66.92 (26.859) | <0.001 |
Figure 1Flipchart summarizing the results of both culture and specific – 16S rDNA for 44 total hip and total knee samples.
Antimicrobial resistance rates of planktonic and biofilm forms of .
| Antimicrobial | ||||||
|---|---|---|---|---|---|---|
| Planktonic | Biofilm | Planktonic | Biofilm | |||
| Ciprofloxacin | 5 (33.33) | 11 (73.33) | <0.001 | 2 (50) | 3 (75) | <0.001 |
| Moxifloxacin | 9 (60) | 12 (80) | <0.001 | 2 (50) | 3 (75) | <0.001 |
| Erythromycin | 11 (73.33) | 15 (100) | <0.001 | 2 (50) | 4 (100) | <0.001 |
| Linezolid | 0 (0) | 13 (86.66) | <0.001 | 0 (0) | 4 (100) | <0.001 |
| Daptomycin | 1 (6.66) | 15 (100) | <0.001 | 0 (0) | 4 (100) | <0.001 |
| Teicoplanin | 1 (6.66) | 15 (100) | <0.001 | 0 (0) | 4 (100) | <0.001 |
| Vancomycin | 0 (0) | 12 (80) | <0.001 | 0 (0) | 3 (75) | <0.001 |
| Tigecycline | 6 (40) | 10 (66.66) | <0.001 | 1 (25) | 4 (100) | <0.001 |
| Cotrimoxazole | 7 (46.66) | 14 (93.33) | <0.001 | 1 (25) | 4 (100) | <0.001 |